Dr. Mark E George, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 Fax: 651-275-3325 |
Rachel Leigh Seiler, MBBS, MPH Surgery Medicare: Medicare Enrolled Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 Fax: 651-275-3325 |
Eric James Saterbak, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 |
Dr. Timothy M Perkins, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 |
Dr. Elmer Harold Kasperson, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 Fax: 651-351-0827 |
Dr. Kevin John Bjork, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Curve Crest Blvd W, Stillwater, MN 55082 Phone: 651-439-1234 Fax: 651-275-3325 |
Dr. Amy Catherine Fox, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Curve Crest Blvd W, Stillwater Medical Group/regions Healthpartners, Stillwater, MN 55082 Phone: 651-439-1234 |
News Archive
CVRx, Inc. reported the first enrollment of a patient in the HOPE4HF Trial, a study that is evaluating the Rheos System to treat heart failure. The Rheos System uses Baroreflex Activation Therapy® technology, an entirely new non-pharmaceutical approach designed to treat cardiovascular disease. The HOPE4HF Trial is being conducted under an approved investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA).
American Medical Systems Holdings, Inc., a leading provider of world-class devices and therapies for male and female pelvic health, announced today that the company is pleased with yesterday's U.S. Court of Appeals for the Federal Circuit's ruling that reversed a summary judgment and finding for Biolitec, Inc.
BioStorage Technologies, Inc., a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, will expand its European operations with the opening of a new 16,140 square foot (1,499 sq meters) full-service biorepository in Frankfurt, Germany.
NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant protection in the initial animal survival studies of Dengue virus infection. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley.
› Verified 1 days ago